New developments in the antiviral treatment of hepatitis C

被引：10
|
作者：
de Bruijne, J. [1 ]
Weegink, C. J. [1 ]
Jansen, P. L. M. [1 ]
Reesink, H. W. [1 ]
机构：
[1] Univ Amsterdam, Acad Med Ctr, Dept Gastroenterol & Hepatol, AMC Liver Ctr, NL-1105 AZ Amsterdam, Netherlands
来源：
VOX SANGUINIS | 2009年 / 97卷 / 01期
关键词：
PROTEASE INHIBITOR; PEGINTERFERON ALPHA-2A; INITIAL TREATMENT; VIRAL-HEPATITIS; PLUS RIBAVIRIN; DOUBLE-BLIND; VIRUS; COMBINATION; INTERFERON-ALPHA-2B; EPIDEMIOLOGY;
D O I：
10.1111/j.1423-0410.2009.01187.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Recently, reliable in vitro culture systems have been developed which accelerated antiviral therapy research. Many new specifically targeted antiviral therapies for hepatitis C (STAT-C) and treatment strategies are evaluated in clinical trials. These new antiviral agents are expected to improve treatment significantly with potentially shorter treatment duration. The most promising antiviral agents will be reviewed.
引用
收藏
页码：1 / 12
页数：12
相关论文
共 50 条
  • [41] Effectivity of treatment of direct antiviral agents in the hepatitis C treatment
    Marin-Ariza, Inmaculada
    Araujo, Francisco
    Campos-Davila, Emilio
    Alvarez-Miralles, Rafael
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2017, 39 (01) : 266 - 266
  • [42] New antiviral treatment of HCV infected young haemophiliacs -expectations to cure hepatitis C
    Koehler-Vajta, K.
    Denk, G.
    Wettstein, M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 347 - 347
  • [43] Antiviral treatment for cirrhosis due to hepatitis C: a review
    Somasundaram, Aravindh
    Venkataraman, Jayanthi
    SINGAPORE MEDICAL JOURNAL, 2012, 53 (04) : 231 - 235
  • [44] Ophthalmologic complications of antiviral therapy in hepatitis C treatment
    Roderick O'Day
    Mark C Gillies
    Golo Ahlenstiel
    World Journal of Gastroenterology, 2013, (45) : 8227 - 8237
  • [45] Antiviral treatment initiation costs in chronic hepatitis C
    Siebert, U
    Wasem, J
    Rossol, S
    Sroczynski, G
    Aidelsburger, P
    Ravens-Sieberer, U
    Kurth, BM
    Manns, MP
    McHutchison, JG
    Wong, JB
    GUT, 2005, 54 (01) : 172 - 173
  • [46] Combined antiviral options for the treatment of chronic hepatitis C
    Medina, J
    García-Buey, L
    Moreno-Monteagudo, JA
    Trapero-Marugán, M
    Moreno-Otero, R
    ANTIVIRAL RESEARCH, 2003, 60 (02) : 135 - 143
  • [47] Direct antiviral agents (DAAs) - A new age in the treatment of hepatitis C virus infection
    Spengler, Ulrich
    PHARMACOLOGY & THERAPEUTICS, 2018, 183 : 118 - 126
  • [48] New direct-acting antiviral agents for the treatment of chronic hepatitis C in 2014
    Cornberg, M.
    Siederdissen, C. Hoener Zu
    Maasoumy, B.
    Manns, M. P.
    INTERNIST, 2014, 55 (04): : 390 - +
  • [49] Therapeutic potential of RNA interference: a new molecular approach to antiviral treatment for hepatitis C
    Motavaf, M.
    Safari, S.
    Alavian, S. M.
    JOURNAL OF VIRAL HEPATITIS, 2012, 19 (11) : 757 - 765
  • [50] Antiviral treatment for hepatitis C cirrhosis: Is the effort justified?
    Black, Martin
    Thomas, Rebecca
    ANNALS OF INTERNAL MEDICINE, 2008, 149 (06) : 427 - W80
12345